Serum hyaluronan (HA) levels were measured in a rat model of collagen
arthritis using a sandwich enzyme-linked immunosorbent assay. Values b
ecame elevated as the arthritis developed, correlating with its severi
ty. Daily subcutaneous treatment with cyclosporin at the dose of 25 mg
/kg per day for fourteen days completely prevented anti-type II collag
en antibody production and the serum HA increase as well as developmen
t of collagen arthritis. HA in the blood may thus provide a good quant
itative marker for joint disease in rat collagen arthritis with potent
ial as a tool for evaluation of drug efficacy in this experimental mod
el.